Home › Opioid Overdose › Illinois › Chicago
Opioid Overdose clinical trials in Chicago, IL
5 studies for Opioid Overdose are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Brenipatide in Participants With Opioid Use Disorder
RecruitingPhase 2
- Re:Cognition Health - Chicago, Chicago
Integrating MOUD in Nonmedical Community Settings (Better Together)
Recruiting
- University of Illinois- Chicago, Chicago
Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder
RecruitingPhase 2
- Ruth M. Rothstein CORE Center, Chicago
Implementing Contingency Management for Stimulant Use in Specialty Addiction Treatment Organizations
Recruiting
- ACCESS Community Health Networks, Chicago
- Community Outreach Intervention Projects, Chicago
- Family Guidance Centers, Chicago
Remotely Observed Methadone Evaluation II
RecruitingPhase 2
- FGC Wabash, Chicago
About Opioid Overdose
Opioid overdose leads to slowing or stopping of breathing and sometimes death. You can take steps to help prevent an overdose, and respond to one with naloxone.
More about Opioid Overdose on MedlinePlus
Opioid Overdose trials in other cities
- New Haven, CT19 studies
- Baltimore, MD18 studies
- Philadelphia, PA14 studies
- New York City, NY13 studies
- Boston, MA11 studies
- Salt Lake City, UT8 studies
- Charleston, SC7 studies
- San Francisco, CA6 studies
- Birmingham, AL6 studies
- Pittsburgh, PA6 studies
- Ann Arbor, MI5 studies
- Minneapolis, MN5 studies
Other studies in Chicago
- Breast Cancer59 studies
- Non-Small Cell Lung Cancer59 studies
- Cancer (all types)51 studies
- Prostate Cancer45 studies
- Lung Cancer43 studies
- Metastatic Cancer42 studies
- Obesity40 studies
- Ovarian Cancer36 studies
- Colorectal Cancer32 studies
- Stroke31 studies
- Head and Neck Squamous Cell Carcinoma29 studies
- Overweight29 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.